Tailored team approach shows promise for IBS sufferers
NCT ID NCT07534930
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a personalized treatment plan for adults with moderate-to-severe IBS. Participants receive a combination of medical care, dietary guidance, psychological therapy, and physical therapy, chosen in an order that suits them. The goal is to reduce IBS symptoms by at least 50 points on a severity scale. The study involves 150 people and lasts 12 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Multidisciplinary treatment including medical management, dietary advice, psychological therapy, and physiotherapy
What this could lead to
If successful, this approach could offer a personalized, effective way to manage IBS symptoms and improve quality of life.
What could go wrong
This is a single-center study with 150 participants, so results may not apply to everyone. The treatment is complex and requires commitment, and not all participants may respond.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IBS (IRRITABLE BOWEL SYNDROME) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Linköping University Hospital
Linköping, Linköping, 58185, Sweden